MOTS-c dosage

MOTS-c injectable dosage

Reported injectable protocols use 5–10 mg per administration, daily for 8-12 weeks. A lower-frequency reported subcutaneous pattern uses 2.5 mg per injection two times weekly; the same source also lists a two-to-three-times-weekly frequency over 8–12 weeks. This should be read separately from a daily schedule rather than combined with its daily amount.[1][2][3][10]

MOTS-c is a mitochondria-derived peptide involved in metabolic stress and AMPK-related signaling. Its proposed purpose concerns insulin sensitivity and muscle-energy adaptation.[1][2][4][3]

Frequency and timing

Common timing is morning or before a workout.[3]

Cycle length and breaks

Injectable: 8-12 weeks. A standard break interval between courses is not established.[1][2][3]

Approval and product quality

MOTS-c is not an FDA-approved drug.[5][6][9]

Side effects and long-term safety

Local injection-site tolerance is a practical concern. Chronic human safety, immunogenicity, long-term mitochondrial-signaling exposure and durable metabolic effects remain unresolved.[2][3][5][6]

Route-specific dosing limits

Unapproved injectable quality, immune response, and metabolic-disease context are the main practical caution areas. Additional schedules attributed to Everything Peptide are reported patterns; citing research does not make these schedules clinically established or approved product instructions.[6][9][3][10]